Gibson Dunn Advised on Sale of NewBridge Pharmaceuticals to Affiliate of DKSH Holding
Firm News | October 26, 2026
Gibson Dunn advised on the sale of NewBridge Pharmaceuticals Limited to an affiliate of DKSH Holding Ltd, a SIX (Switzerland) listed entity.
NewBridge is a healthcare commercialization platform headquartered in the UAE that distributes pharmaceutical products across the Middle East and Africa. Completion of the sale is subject to customary closing conditions, including regulatory approvals.
The firm’s London corporate team was led by partner Amar Madhani and associate Joanne Hughes and included associates Freddie Wright and Francesco Mancuso. Partner Ben Fryer advised on tax matters, and partner Richard Surtees advised on employment and incentive matters. Ryan Murr and Branden Berns acted as relationship partners on the deal.